Anti-Siglec-2 / CD22 Reference Antibody (pinatuzumab vedotin)

• Catalog Number: orb1805460
• Category: Antibodies
• Description: Anti-Siglec-2 / CD22 Reference Antibodyand Monomethyl auristatin E (MMAE) used for the study of hematological malignancies.
• Clonality: Monoclonal
• Tested applications: ELISA, FA, FACS, Kinetics
• Reactivity: Human
• Isotype: IgG
• Purity: > 95%
• Conjugation: Unconjugated
• MW: 145.5 kDa
• Target: Siglec-2 / CD22
• Endotoxins: < 1 EU/mg
• Storage: Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
• Buffer/Preservatives: 100 mM Pro-Ac 20 mM Arg pH 5.0
• Note: For research use only
• Expiration Date: 12 months from date of receipt.

Anti-Siglec-2 / CD22 Reference Antibody (pinatuzumab vedotin) on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90%.

The purity of Anti-Siglec-2 / CD22 Reference Antibody (pinatuzumab vedotin)is more than 95% ;determined by SEC-HPLC.

Immobilized human Siglec 2 / CD22; His Tag at 2 μg/mL can bind Anti-Siglec-2 / CD22 Reference Antibody (pinatuzumab vedotin);EC50=0.008851μg/mL.